文献速递胃肠外科围术期管理与 ERAS

晚期上皮性卵巢癌间隔期肿瘤细胞减灭术联合腹腔热灌注化疗的腹腔镜与开腹入路比较:一项匹配对照研究

Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study.
PubMed 文献 · Surg Endosc · 2023-10-30

该回顾性匹配队列研究纳入53例原发晚期上皮性卵巢癌且PCI≤10的患者,比较间隔期腹腔镜与开腹肿瘤细胞减灭术联合腹腔热灌注化疗的近期结局。腹腔镜组住院时间更短(5.6±1.9 vs 9.7±9.8天,p<0.001),恢复全身化疗时间更短(4.3±1.9 vs 10.3±16.8周,p=0.003),术后并发症无显著差异,2年OS和DFS两组相似。作者认为该入路与更短住院和更早恢复全身治疗相关,但需进一步前瞻性研究才能推荐。

要点

  • 腹腔镜组住院时间5.6±1.9天,开腹组9.7±9.8天,p<0.001。
  • 腹腔镜组恢复全身化疗时间4.3±1.9周,开腹组10.3±16.8周,p=0.003。
  • 两组术后并发症无显著差异,2年OS和DFS相似(p=0.96;p=0.786)。

核心结论

  • 作者认为,对严格筛选的原发晚期上皮性卵巢癌患者,间隔期腹腔镜肿瘤细胞减灭术联合腹腔热灌注化疗与开腹入路相比,住院时间更短、恢复全身治疗更早,且肿瘤学结果相似。
  • 作者指出需要进一步前瞻性研究才能推荐这一新入路用于这些严格筛选的患者。

研究设计与样本

  • 回顾性分析一个前瞻性维护的数据库,纳入2016年1月至2021年12月期间接受间隔期肿瘤细胞减灭术联合腹腔热灌注化疗的254例患者。
  • 筛选原发疾病且癌播散局限(PCI≤10)的患者,最终53例入选并分为两组:腹腔镜组14例,开腹组39例。
  • 比较两组的总生存、无病生存和围术期结局。

主要发现

  • 腹腔镜组住院时间5.6±1.9天,开腹组9.7±9.8天,p<0.001。
  • 腹腔镜组恢复全身化疗时间4.3±1.9周,开腹组10.3±16.8周,p=0.003。
  • 两组术后并发症无显著差异。
  • 腹腔镜组2年OS为100%、DFS为62%,开腹组分别为92%和60%(p=0.96;p=0.786)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出需要进一步前瞻性研究才能推荐这一新入路用于这些严格筛选的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of the laparoscopic approach for the treatment of carcinomatosis from epithelial ovarian cancer (EOC) is controversial. The aim of this study was to compare the short-term outcomes of both laparoscopic and open approach for interval CRS+HIPEC in a matched cohort of patients with advanced EOC. METHODS: A retrospective analysis of a prospectively maintained database including 254 patients treated with interval CRS-HIPEC between January 2016 and December 2021 was performed. Patients with primary disease and limited carcinomatosis (PCI ≤ 10) were selected. A comparative analysis of patients treated by either open (O-CRS-HIPEC) or the laparoscopic (L-CRS-HIPEC) approach was conducted. Overall survival (OS), disease-free survival (DFS), and perioperative outcomes were analysed. RESULTS: Fifty-three patients were finally selected and enrolled into two comparable groups in this study. Of these, 14 patients were treated by interval L-CRS-HIPEC and 39 by interval O-CRS-HIPEC. The L-CRS-HIPEC group had a shorter hospital stay (5.6 ± 1.9 vs. 9.7 ± 9.8 days; p < 0.001) and a shorter time to return to systemic chemotherapy (4.3 ± 1.9 vs. 10.3 ± 16.8 weeks; p = 0.003). There were no significant differences in postoperative complications between both groups. The 2-year OS and DFS was 100% and 62% in the L-CRS-HIPEC group versus 92% and 60% in the O-CRS-HIPEC group, respectively (p = 0.96; p = 0.786). CONCLUSION: This study suggests that the use of interval L-CRS-HIPEC for primary advanced EOC is associated with shorter hospital stay and return to systemic treatment while obtaining similar oncological results compared to the open approach. Further prospective research is needed to recommend this new approach for these strictly selected patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Durán-Martínez M, Gómez-Dueñas G, Rodriguez-Ortíz L, et al. Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study. Surg Endosc. 2023. PMID: 37903884. doi:10.1007/s00464-023-10508-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。